trial · primary record
GEN1107
Endometrial Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 33 |
| Primary completion | 2025-08-18 |
| Primary endpoint | Number of Participants With Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT06171789 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:11.901Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06171789
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.